We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Groundbreaking Cauterization Device to Revolutionize Field Of Biopsy Closure

By HospiMedica International staff writers
Posted on 21 Feb 2024
Print article
Image: Live clinical cases have been completed with the KRONOS biopsy closure device (Photo courtesy of Single Pass)
Image: Live clinical cases have been completed with the KRONOS biopsy closure device (Photo courtesy of Single Pass)

With over 27 million new cancer cases anticipated in the next 17 years, there is a need to improve the biopsy experience. Anxiety is common among patients undergoing biopsies, particularly due to fears of bleeding complications. Now, a groundbreaking cautery device can prevent or halt bleeding during co-axial biopsy procedures and is especially beneficial in biopsies of the liver, kidney, lungs, and breasts.

Single Pass, Inc.’s (Lake Forest, CA, USA) KRONOS biopsy closure cautery device is the only single-use tool for co-axial biopsies that uses a patented method of cauterizing damaged tissue to prevent bleeding. This innovation translates to fewer complications and reduced hospital stays. The device is compact, hand-held, and integrates seamlessly into the biopsy process as it can fit with an 18-gauge guide needle or larger. This disposable tool features a probe tip designed to "heat-seal" the biopsy-damaged tissue within minutes, thus speeding up the cauterization process. Given its ability to go through a biopsy guide needle, it does not pose additional risks and is a safe and effective solution for at-risk patients, easing anxiety for both patients and medical staff.

Typically, a four to eight-hour observation period follows a biopsy to monitor for any adverse events. With KRONOS, this waiting time can be significantly reduced or even bypassed. Some health experts believe that the device might also prevent tumor seeding, a scenario where cancer cells spread following a biopsy. The KRONOS device operates on two AA batteries housed in its handle, offering a lightweight, easy-to-use, and disposable design. In two separate case studies involving 60 patients who underwent lung, liver, or kidney biopsies, KRONOS effectively prevented bleeding, resulting in no adverse events and consistently blood-free biopsy channels. Additionally, Single Pass has recently reported the successful application of this innovative device in real-life cases, showcasing its remarkable performance and potential to transform biopsy closure techniques.

 

Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Ultra Low Floor Level Bed
Solite Pro

Print article

Channels

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.